| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF419 ZFP42 ZNF219 ZNF337 FEZF1 ZNF408 ZNF316 ZBTB9 ZFP92 ZNF221 ZNF319 MGA ZNF865 ZKSCAN5 ZNF786 ZNF169 TP53 ZNF697 VDR TBX6 | 6.00e-11 | 1459 | 49 | 20 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF419 ZFP42 ZNF219 ZNF337 FEZF1 ZNF408 ZNF316 ZBTB9 ZFP92 ZNF221 ZNF319 MGA ZKSCAN5 ZNF786 ZNF169 TP53 ZNF697 VDR TBX6 | 2.98e-10 | 1412 | 49 | 19 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF419 ZFP42 ZNF219 FEZF1 ZNF408 ZNF316 ZBTB9 ZFP92 ZNF221 ZNF319 MGA ZNF865 ZKSCAN5 ZNF786 TP53 ZNF697 VDR TBX6 | 3.22e-10 | 1244 | 49 | 18 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF419 ZFP42 ZNF219 FEZF1 ZNF408 ZNF316 ZBTB9 ZFP92 ZNF221 ZNF319 MGA ZNF865 ZKSCAN5 ZNF786 TP53 ZNF697 VDR TBX6 | 4.55e-10 | 1271 | 49 | 18 | GO:0000987 |
| GeneOntologyMolecularFunction | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity | 5.90e-06 | 2 | 49 | 2 | GO:0004572 | |
| GeneOntologyMolecularFunction | mannosyl-oligosaccharide mannosidase activity | 2.62e-04 | 10 | 49 | 2 | GO:0015924 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 3.83e-04 | 12 | 49 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 5.27e-04 | 14 | 49 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | alpha-mannosidase activity | 6.07e-04 | 15 | 49 | 2 | GO:0004559 | |
| GeneOntologyMolecularFunction | mannosidase activity | 6.93e-04 | 16 | 49 | 2 | GO:0015923 | |
| GeneOntologyBiologicalProcess | negative regulation of transforming growth factor beta receptor signaling pathway | 1.88e-05 | 138 | 49 | 5 | GO:0030512 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 3.31e-05 | 4 | 49 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | BCLAF3 PRDM9 ZFP42 ZNF219 PPRC1 POGZ ZNF319 MGA ZNF786 TP53 VDR TBX6 | 7.46e-05 | 1390 | 49 | 12 | GO:0045944 |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 9.07e-05 | 192 | 49 | 5 | GO:0017015 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 9.76e-05 | 195 | 49 | 5 | GO:1903844 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 1.39e-04 | 336 | 49 | 6 | GO:0071560 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 1.53e-04 | 8 | 49 | 2 | GO:0071694 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 1.55e-04 | 343 | 49 | 6 | GO:0071559 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.65e-04 | 218 | 49 | 5 | GO:0090101 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.65e-04 | 347 | 49 | 6 | GO:0090092 | |
| GeneOntologyBiologicalProcess | sequestering of extracellular ligand from receptor | 3.00e-04 | 11 | 49 | 2 | GO:0035581 | |
| GeneOntologyBiologicalProcess | mannose metabolic process | 3.59e-04 | 12 | 49 | 2 | GO:0006013 | |
| GeneOntologyBiologicalProcess | extracellular regulation of signal transduction | 4.24e-04 | 13 | 49 | 2 | GO:1900115 | |
| GeneOntologyBiologicalProcess | extracellular negative regulation of signal transduction | 4.24e-04 | 13 | 49 | 2 | GO:1900116 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 4.88e-04 | 276 | 49 | 5 | GO:0007179 | |
| GeneOntologyBiologicalProcess | bone trabecula formation | 4.94e-04 | 14 | 49 | 2 | GO:0060346 | |
| HumanPheno | Abnormal upper to lower segment ratio | 2.42e-05 | 3 | 15 | 2 | HP:0012772 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF419 PRDM9 ZFP42 ZNF219 ZNF337 FEZF1 ZNF408 ZNF316 ZBTB9 ZFP92 POGZ ZNF221 ZNF223 ZNF319 ZNF865 ZKSCAN5 ZNF654 ZNF786 ZNF169 ZNF697 | 1.64e-15 | 775 | 49 | 20 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF419 PRDM9 ZFP42 ZNF219 ZNF337 FEZF1 ZNF408 ZNF316 ZBTB9 ZFP92 POGZ ZNF221 ZNF223 ZNF319 ZNF865 ZKSCAN5 ZNF654 ZNF786 ZNF169 ZNF697 | 1.72e-15 | 777 | 49 | 20 | PS00028 |
| Domain | - | ZNF419 PRDM9 ZFP42 ZNF219 ZNF337 FEZF1 ZNF408 ZNF316 ZBTB9 ZFP92 ZNF221 ZNF223 ZNF319 ZNF865 ZKSCAN5 ZNF654 ZNF786 ZNF169 ZNF697 | 2.37e-15 | 679 | 49 | 19 | 3.30.160.60 |
| Domain | Znf_C2H2-like | ZNF419 PRDM9 ZFP42 ZNF219 ZNF337 FEZF1 ZNF408 ZNF316 ZBTB9 ZFP92 POGZ ZNF221 ZNF223 ZNF319 ZNF865 ZKSCAN5 ZNF654 ZNF786 ZNF169 ZNF697 | 2.72e-15 | 796 | 49 | 20 | IPR015880 |
| Domain | Znf_C2H2 | ZNF419 PRDM9 ZFP42 ZNF219 ZNF337 FEZF1 ZNF408 ZNF316 ZBTB9 ZFP92 POGZ ZNF221 ZNF223 ZNF319 ZNF865 ZKSCAN5 ZNF654 ZNF786 ZNF169 ZNF697 | 3.37e-15 | 805 | 49 | 20 | IPR007087 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF419 PRDM9 ZFP42 ZNF219 ZNF337 FEZF1 ZNF408 ZNF316 ZBTB9 ZFP92 ZNF221 ZNF223 ZNF319 ZNF865 ZKSCAN5 ZNF654 ZNF786 ZNF169 ZNF697 | 3.52e-15 | 694 | 49 | 19 | IPR013087 |
| Domain | ZnF_C2H2 | ZNF419 PRDM9 ZFP42 ZNF219 ZNF337 FEZF1 ZNF408 ZNF316 ZBTB9 ZFP92 POGZ ZNF221 ZNF223 ZNF319 ZNF865 ZKSCAN5 ZNF654 ZNF786 ZNF169 ZNF697 | 3.62e-15 | 808 | 49 | 20 | SM00355 |
| Domain | zf-C2H2 | ZNF419 PRDM9 ZNF219 ZNF337 FEZF1 ZNF408 ZNF316 ZBTB9 ZFP92 POGZ ZNF221 ZNF223 ZNF319 ZNF865 ZKSCAN5 ZNF786 ZNF169 ZNF697 | 5.63e-14 | 693 | 49 | 18 | PF00096 |
| Domain | KRAB | ZNF419 PRDM9 ZNF337 ZNF316 ZFP92 ZNF221 ZNF223 ZKSCAN5 ZNF786 ZNF169 | 2.50e-08 | 358 | 49 | 10 | PF01352 |
| Domain | KRAB | ZNF419 PRDM9 ZNF337 ZNF316 ZFP92 ZNF221 ZNF223 ZKSCAN5 ZNF786 ZNF169 | 3.32e-08 | 369 | 49 | 10 | SM00349 |
| Domain | KRAB | ZNF419 PRDM9 ZNF337 ZNF316 ZFP92 ZNF221 ZNF223 ZKSCAN5 ZNF786 ZNF169 | 3.41e-08 | 370 | 49 | 10 | IPR001909 |
| Domain | zf-C2H2_6 | ZNF419 PRDM9 FEZF1 ZNF408 ZNF316 ZFP92 ZNF865 ZKSCAN5 ZNF169 | 1.09e-07 | 314 | 49 | 9 | PF13912 |
| Domain | KRAB | ZNF419 ZNF337 ZNF316 ZFP92 ZNF221 ZNF223 ZKSCAN5 ZNF786 ZNF169 | 3.30e-07 | 358 | 49 | 9 | PS50805 |
| Domain | FBN | 2.02e-05 | 3 | 49 | 2 | IPR011398 | |
| Domain | cEGF | 4.23e-05 | 26 | 49 | 3 | IPR026823 | |
| Domain | cEGF | 4.23e-05 | 26 | 49 | 3 | PF12662 | |
| Domain | Growth_fac_rcpt_ | 5.40e-05 | 156 | 49 | 5 | IPR009030 | |
| Domain | - | 6.71e-05 | 5 | 49 | 2 | 1.20.1270.50 | |
| Domain | - | 6.71e-05 | 5 | 49 | 2 | 3.20.110.10 | |
| Domain | Glyco_hydro_38_C | 6.71e-05 | 5 | 49 | 2 | IPR011682 | |
| Domain | Alpha-mann_mid | 6.71e-05 | 5 | 49 | 2 | SM00872 | |
| Domain | Glyco_hydro_38_cen | 6.71e-05 | 5 | 49 | 2 | IPR015341 | |
| Domain | Glyco_hydro_57/38_cen | 6.71e-05 | 5 | 49 | 2 | IPR028995 | |
| Domain | Alpha-mann_mid | 6.71e-05 | 5 | 49 | 2 | PF09261 | |
| Domain | Glyco_hydro_38C | 6.71e-05 | 5 | 49 | 2 | PF07748 | |
| Domain | Glyco_hydro_38_N | 6.71e-05 | 5 | 49 | 2 | IPR000602 | |
| Domain | Glyco_hydro_38/57_N | 6.71e-05 | 5 | 49 | 2 | IPR027291 | |
| Domain | Glyco_hydro_38 | 6.71e-05 | 5 | 49 | 2 | PF01074 | |
| Domain | EGF_CA | 7.58e-05 | 86 | 49 | 4 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 1.21e-04 | 97 | 49 | 4 | IPR018097 | |
| Domain | EGF_CA | 1.31e-04 | 99 | 49 | 4 | PS01187 | |
| Domain | ASX_HYDROXYL | 1.36e-04 | 100 | 49 | 4 | PS00010 | |
| Domain | Glyco_hydro/deAcase_b/a-brl | 1.40e-04 | 7 | 49 | 2 | IPR011330 | |
| Domain | TB | 1.40e-04 | 7 | 49 | 2 | PF00683 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.71e-04 | 106 | 49 | 4 | IPR000152 | |
| Domain | - | 1.87e-04 | 8 | 49 | 2 | 3.90.290.10 | |
| Domain | TB | 2.40e-04 | 9 | 49 | 2 | PS51364 | |
| Domain | TB_dom | 2.40e-04 | 9 | 49 | 2 | IPR017878 | |
| Domain | EGF_CA | 2.93e-04 | 122 | 49 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.11e-04 | 124 | 49 | 4 | IPR001881 | |
| Domain | p53-like_TF_DNA-bd | 3.62e-04 | 53 | 49 | 3 | IPR008967 | |
| Domain | EGF_3 | 3.67e-04 | 235 | 49 | 5 | PS50026 | |
| Domain | EGF | 3.67e-04 | 235 | 49 | 5 | SM00181 | |
| Domain | EGF_1 | 5.33e-04 | 255 | 49 | 5 | PS00022 | |
| Domain | EGF-like_CS | 5.92e-04 | 261 | 49 | 5 | IPR013032 | |
| Domain | - | 6.01e-04 | 14 | 49 | 2 | 2.60.40.1180 | |
| Domain | EGF_2 | 6.34e-04 | 265 | 49 | 5 | PS01186 | |
| Domain | Glyco_hydro_b | 6.93e-04 | 15 | 49 | 2 | IPR013780 | |
| Domain | Gal_mutarotase_SF_dom | 8.94e-04 | 17 | 49 | 2 | IPR011013 | |
| Domain | TF_T-box | 8.94e-04 | 17 | 49 | 2 | IPR001699 | |
| Domain | TBOX_3 | 8.94e-04 | 17 | 49 | 2 | PS50252 | |
| Domain | TBOX | 8.94e-04 | 17 | 49 | 2 | SM00425 | |
| Domain | TF_T-box_CS | 8.94e-04 | 17 | 49 | 2 | IPR018186 | |
| Domain | T-box | 8.94e-04 | 17 | 49 | 2 | PF00907 | |
| Domain | - | 8.94e-04 | 17 | 49 | 2 | 2.60.40.820 | |
| Domain | TBOX_1 | 8.94e-04 | 17 | 49 | 2 | PS01283 | |
| Domain | TBOX_2 | 8.94e-04 | 17 | 49 | 2 | PS01264 | |
| Domain | hEGF | 2.44e-03 | 28 | 49 | 2 | PF12661 | |
| Domain | EGF-like_dom | 4.08e-03 | 249 | 49 | 4 | IPR000742 | |
| Pubmed | 2.19e-07 | 9 | 49 | 3 | 12122015 | ||
| Pubmed | ZNF219 FBN2 HPN ZNF316 ZBTB9 LRP1 POGZ MGA ZC3H3 ZKSCAN5 TP53 | 3.37e-07 | 1116 | 49 | 11 | 31753913 | |
| Pubmed | 1.69e-06 | 808 | 49 | 9 | 20412781 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 12399449 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 21851253 | ||
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 1.94e-06 | 2 | 49 | 2 | 30044367 | |
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 1.94e-06 | 2 | 49 | 2 | 21440062 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 15131124 | ||
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 1.94e-06 | 2 | 49 | 2 | 20404337 | |
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 1.94e-06 | 2 | 49 | 2 | 8791520 | |
| Pubmed | Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. | 1.94e-06 | 2 | 49 | 2 | 8307578 | |
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 1.94e-06 | 2 | 49 | 2 | 7744963 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 26408953 | ||
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 1.94e-06 | 2 | 49 | 2 | 18006876 | |
| Pubmed | Modulation of the vitamin D3 response by cancer-associated mutant p53. | 1.94e-06 | 2 | 49 | 2 | 20227041 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 8524845 | ||
| Pubmed | Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. | 1.94e-06 | 2 | 49 | 2 | 24833718 | |
| Pubmed | Exome sequencing identified new mutations in a Marfan syndrome family. | 1.94e-06 | 2 | 49 | 2 | 24484584 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 24265020 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 20529844 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 23133647 | ||
| Pubmed | Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. | 1.94e-06 | 2 | 49 | 2 | 1852206 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 16754854 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 25519225 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 12429739 | ||
| Pubmed | Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. | 1.94e-06 | 2 | 49 | 2 | 12524050 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 8120105 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 35419902 | ||
| Pubmed | Fibrillin assembly: dimer formation mediated by amino-terminal sequences. | 1.94e-06 | 2 | 49 | 2 | 10504303 | |
| Pubmed | Immunohistochemical expression of fibrillin-1 and fibrillin-2 during tooth development. | 1.94e-06 | 2 | 49 | 2 | 25524144 | |
| Pubmed | N-Glycan structure analysis using lectins and an alpha-mannosidase activity assay. | 1.94e-06 | 2 | 49 | 2 | 17113875 | |
| Pubmed | Fibrillins 1 and 2 perform partially overlapping functions during aortic development. | 1.94e-06 | 2 | 49 | 2 | 16407178 | |
| Pubmed | Germ cell survival through carbohydrate-mediated interaction with Sertoli cells. | 1.94e-06 | 2 | 49 | 2 | 11778047 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 10359653 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 10825173 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 30201140 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 31163177 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 10449920 | ||
| Pubmed | Calcium, vitamin D, VDR genotypes, and epigenetic and genetic changes in rectal tumors. | 5.83e-06 | 3 | 49 | 2 | 20432164 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 20855508 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 25259922 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 30315595 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 33226370 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 28069388 | ||
| Pubmed | Mechanisms Regulating Acquisition of Platelet-Derived Factor V/Va by Megakaryocytes. | 5.83e-06 | 3 | 49 | 2 | 25800007 | |
| Pubmed | Human eye development is characterized by coordinated expression of fibrillin isoforms. | 1.16e-05 | 4 | 49 | 2 | 25406291 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 20729550 | ||
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 1.16e-05 | 4 | 49 | 2 | 25034023 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 12429738 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 16835936 | ||
| Pubmed | Oncogenic Ras Disrupts Epithelial Integrity by Activating the Transmembrane Serine Protease Hepsin. | 1.16e-05 | 4 | 49 | 2 | 33461973 | |
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 26601954 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 12555245 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 17960397 | ||
| Pubmed | Development, composition, and structural arrangements of the ciliary zonule of the mouse. | 1.94e-05 | 5 | 49 | 2 | 23493297 | |
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 12590922 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 17255108 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 34411563 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 29769563 | ||
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 17567906 | ||
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 7873879 | ||
| Pubmed | 3.82e-05 | 46 | 49 | 3 | 20301533 | ||
| Pubmed | 4.07e-05 | 7 | 49 | 2 | 8617494 | ||
| Pubmed | Regulation of limb patterning by extracellular microfibrils. | 4.07e-05 | 7 | 49 | 2 | 11470817 | |
| Pubmed | Putative functions of extracellular matrix glycoproteins in secondary palate morphogenesis. | 5.42e-05 | 8 | 49 | 2 | 23055981 | |
| Pubmed | Adamts17 is involved in skeletogenesis through modulation of BMP-Smad1/5/8 pathway. | 5.42e-05 | 8 | 49 | 2 | 31201465 | |
| Pubmed | Analysis of polymorphic patterns in candidate genes in Israeli patients with prostate cancer. | 5.42e-05 | 8 | 49 | 2 | 14719475 | |
| Pubmed | ATM and PRDM9 regulate SPO11-bound recombination intermediates during meiosis. | 5.42e-05 | 8 | 49 | 2 | 32051414 | |
| Pubmed | Targeting of bone morphogenetic protein growth factor complexes to fibrillin. | 5.42e-05 | 8 | 49 | 2 | 18339631 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 5.45e-05 | 146 | 49 | 4 | 23892456 | |
| Pubmed | 6.96e-05 | 9 | 49 | 2 | 38844137 | ||
| Pubmed | 8.69e-05 | 10 | 49 | 2 | 30738849 | ||
| Pubmed | HIV-1 gp120 N-linked glycosylation differs between plasma and leukocyte compartments. | 8.69e-05 | 10 | 49 | 2 | 18215327 | |
| Pubmed | 8.69e-05 | 10 | 49 | 2 | 18330979 | ||
| Pubmed | 8.69e-05 | 10 | 49 | 2 | 18314154 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 9.18e-05 | 167 | 49 | 4 | 20362541 | |
| Pubmed | 1.27e-04 | 12 | 49 | 2 | 36779913 | ||
| Pubmed | 1.27e-04 | 12 | 49 | 2 | 26405179 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.33e-04 | 184 | 49 | 4 | 32908313 | |
| Pubmed | 1.40e-04 | 71 | 49 | 3 | 33541421 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.44e-04 | 1105 | 49 | 8 | 35748872 | |
| Pubmed | gp25L/emp24/p24 protein family members of the cis-Golgi network bind both COP I and II coatomer. | 1.50e-04 | 13 | 49 | 2 | 9472029 | |
| Pubmed | 1.59e-04 | 74 | 49 | 3 | 29795351 | ||
| Pubmed | 2.02e-04 | 15 | 49 | 2 | 8892864 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 2.16e-04 | 877 | 49 | 7 | 20211142 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 2.53e-04 | 1201 | 49 | 8 | 35696571 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 2.56e-04 | 1203 | 49 | 8 | 29180619 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 2.60e-04 | 219 | 49 | 4 | 31353912 | |
| Pubmed | 2.61e-04 | 17 | 49 | 2 | 2355006 | ||
| Pubmed | 2.93e-04 | 18 | 49 | 2 | 10198638 | ||
| Pubmed | Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development. | 2.93e-04 | 18 | 49 | 2 | 35503090 | |
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 2.93e-04 | 18 | 49 | 2 | 39040056 | |
| Pubmed | 3.64e-04 | 20 | 49 | 2 | 12560567 | ||
| Pubmed | 3.64e-04 | 20 | 49 | 2 | 12743021 | ||
| Pubmed | Effect of germ-line genetic variation on breast cancer survival in a population-based study. | 3.64e-04 | 20 | 49 | 2 | 12036913 | |
| Pubmed | 4.41e-04 | 22 | 49 | 2 | 8673525 | ||
| Pubmed | Effect of various glycosidase treatments on the resistance of the HIV-1 envelope to degradation. | 4.41e-04 | 22 | 49 | 2 | 9109416 | |
| Pubmed | 4.41e-04 | 22 | 49 | 2 | 11530211 | ||
| Pubmed | 4.83e-04 | 23 | 49 | 2 | 8093218 | ||
| Pubmed | Glycosylation inhibitors block the expression of LAV/HTLV-III (HIV) glycoproteins. | 4.83e-04 | 23 | 49 | 2 | 3099781 | |
| Interaction | NOTCH2 interactions | HSCB ZNF419 ZNF219 FBN2 ZNF408 ZNF316 ZBTB9 ZNF865 ZC3H3 RPL17 | 5.91e-08 | 423 | 49 | 10 | int:NOTCH2 |
| Interaction | KRTAP10-7 interactions | 4.88e-07 | 293 | 49 | 8 | int:KRTAP10-7 | |
| Interaction | LTBP2 interactions | 1.95e-06 | 85 | 49 | 5 | int:LTBP2 | |
| Interaction | ZNF92 interactions | 9.60e-06 | 55 | 49 | 4 | int:ZNF92 | |
| Interaction | TRIM41 interactions | 1.61e-05 | 223 | 49 | 6 | int:TRIM41 | |
| Interaction | VWCE interactions | 1.76e-05 | 64 | 49 | 4 | int:VWCE | |
| Interaction | FBLN2 interactions | 1.99e-05 | 66 | 49 | 4 | int:FBLN2 | |
| Interaction | ZNF460 interactions | 2.10e-05 | 138 | 49 | 5 | int:ZNF460 | |
| Interaction | RSBN1 interactions | 4.39e-05 | 161 | 49 | 5 | int:RSBN1 | |
| Interaction | P3H2 interactions | 4.72e-05 | 29 | 49 | 3 | int:P3H2 | |
| Interaction | LRP1B interactions | 5.40e-05 | 85 | 49 | 4 | int:LRP1B | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 1.63e-03 | 1192 | 49 | 6 | chr19q13 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF419 PRDM9 ZFP42 ZNF219 ZNF337 FEZF1 ZNF408 ZNF316 ZBTB9 ZFP92 ZNF221 ZNF223 ZNF319 ZNF865 ZKSCAN5 ZNF786 ZNF169 ZNF697 | 4.26e-16 | 718 | 37 | 18 | 28 |
| GeneFamily | Mannosidases alpha class 2 | 4.06e-05 | 5 | 37 | 2 | 1194 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 5.44e-04 | 17 | 37 | 2 | 1197 | |
| GeneFamily | T-boxes | 6.11e-04 | 18 | 37 | 2 | 766 | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 10uM; PC3; HT_HG-U133A | 3.87e-06 | 196 | 49 | 6 | 3732_UP | |
| Drug | Aztreonam [78110-38-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 4.35e-06 | 200 | 49 | 6 | 5535_UP | |
| Disease | connective tissue disease (implicated_via_orthology) | 7.44e-06 | 3 | 47 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | scoliosis (is_implicated_in) | 1.49e-05 | 4 | 47 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 6.91e-05 | 8 | 47 | 2 | DOID:4783 (biomarker_via_orthology) | |
| Disease | basal cell carcinoma (is_marker_for) | 6.91e-05 | 8 | 47 | 2 | DOID:2513 (is_marker_for) | |
| Disease | pulse pressure measurement, migraine without aura, susceptibility to, 4 | 8.88e-05 | 9 | 47 | 2 | EFO_0005763, MONDO_0011847 | |
| Disease | aortic aneurysm | 1.11e-04 | 10 | 47 | 2 | EFO_0001666 | |
| Disease | testosterone measurement | 1.58e-04 | 1275 | 47 | 9 | EFO_0004908 | |
| Disease | basal cell carcinoma (is_implicated_in) | 1.62e-04 | 12 | 47 | 2 | DOID:2513 (is_implicated_in) | |
| Disease | T-Cell Lymphoma | 2.94e-04 | 16 | 47 | 2 | C0079772 | |
| Disease | bone density | 3.73e-04 | 388 | 47 | 5 | EFO_0003923 | |
| Disease | squamous cell carcinoma (is_implicated_in) | 3.74e-04 | 18 | 47 | 2 | DOID:1749 (is_implicated_in) | |
| Disease | descending aortic diameter | 3.78e-04 | 88 | 47 | 3 | EFO_0021788 | |
| Disease | low density lipoprotein cholesterol measurement, response to escitalopram, response to citalopram | 6.70e-04 | 24 | 47 | 2 | EFO_0004611, EFO_0006329, EFO_0007871 | |
| Disease | spontaneous coronary artery dissection | 1.12e-03 | 31 | 47 | 2 | EFO_0010820 | |
| Disease | liver cirrhosis (biomarker_via_orthology) | 1.35e-03 | 34 | 47 | 2 | DOID:5082 (biomarker_via_orthology) | |
| Disease | melanoma (is_implicated_in) | 1.35e-03 | 34 | 47 | 2 | DOID:1909 (is_implicated_in) | |
| Disease | pulse pressure measurement | 1.46e-03 | 1392 | 47 | 8 | EFO_0005763 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FDRNVPRICGVCGDR | 16 | P11473 | |
| VGCGFRRARPKFEQV | 56 | Q9NZL9 | |
| ICCQFDFKRLPGGRF | 366 | Q16706 | |
| RKRAPPCNNDFCRLG | 1041 | Q8IWI9 | |
| FNPRFKRAGCIVCNT | 66 | O00214 | |
| IGFKCRCRPGFRLKD | 2961 | Q07954 | |
| VFFPRCLLVQRCGGN | 291 | Q9GZP0 | |
| PVCVRFERRGCVHGN | 1046 | Q9Y4D7 | |
| GRNSFEVRVCACPGR | 266 | P04637 | |
| PRGRFLAAICQDCGR | 141 | P05981 | |
| KPYVCRECGRGFSRQ | 606 | Q9NQV7 | |
| VRPFKSNFRGGRCQP | 646 | A2AJT9 | |
| CRRGFIPNIRTGACQ | 231 | P35555 | |
| DRRFLQLNKCPACFG | 46 | Q8NDZ4 | |
| ICCQFDFKRLPGGRI | 366 | P49641 | |
| CRRGFIPNIRTGACQ | 261 | P35556 | |
| PFDLCFGGRRQFCKR | 1611 | Q5VV67 | |
| KNCNVDPRGCFRLFF | 231 | Q7L3B6 | |
| VRCERGCPQNRFGVG | 1286 | O75095 | |
| GREDRFFCPQCRALQ | 51 | Q8IWL3 | |
| LIVQLRFCGRQPCGR | 71 | Q15628 | |
| RPFVCKVCGKGFRQA | 286 | A0PJY2 | |
| DGGRKICPRCNAQFR | 371 | Q7Z3K3 | |
| QCVPFRRYNGGVGRC | 56 | P18621 | |
| MRRNPFGVDICCRKG | 41 | Q9NPF2 | |
| FRGCKVRQCGLGGRQ | 66 | A0PK11 | |
| GERPFACRECGKAFR | 316 | A6NM28 | |
| FARRGACPRGAQCQL | 781 | Q8IXZ2 | |
| ERRFPCGVCQKSFKQ | 221 | P0CJ78 | |
| PFKCEQCGRGFRCRS | 231 | Q9UK11 | |
| FLCPHCGRAFRQRGN | 496 | Q9H9D4 | |
| CFGTFNDQKRGICRP | 121 | Q07011 | |
| SFACVICGRKFRNRG | 571 | Q8IZM8 | |
| RACNRRLFVPREGCG | 381 | Q9H254 | |
| PFAKGFRENGRNCKR | 266 | O95947 | |
| CGVGPRFVRCRNATA | 161 | A6NDV4 | |
| GEKRFVCPFQGCNRR | 271 | Q96MM3 | |
| RPFACGECGKGFVRR | 351 | Q5TEC3 | |
| FSLRPFGCGICNKRF | 406 | Q96C00 | |
| GNQELFPCEVCGRRF | 11 | Q5TFG8 | |
| KPFRCAKCGRNFRQR | 451 | Q8N393 | |
| GERPFRCGECQKAFK | 311 | Q9P2F9 | |
| KPFRCDTCGKNFRQR | 336 | Q9UK13 | |
| EKPFRCADCGRGFAQ | 856 | A6NFI3 | |
| GEKPFKCNECGRLFR | 451 | Q96HQ0 | |
| RFPCPVCGKRFRFNS | 56 | Q9P2Y4 | |
| RPFVCQECGRGFRQK | 316 | Q14929 | |
| RPFKCNECGKGFGRR | 631 | Q9Y2L8 | |
| FFCRDCGRGFTLKPN | 516 | Q9Y3M9 |